American Healthcare REIT (NYSE:AHR) Price Target Raised to $55.00 at Citigroup

American Healthcare REIT (NYSE:AHRGet Free Report) had its target price raised by equities researchers at Citigroup from $52.00 to $55.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Citigroup’s target price would indicate a potential upside of 3.48% from the stock’s current price.

Several other brokerages have also recently commented on AHR. Zacks Research cut shares of American Healthcare REIT from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 1st. Scotiabank raised their price objective on American Healthcare REIT from $47.00 to $55.00 and gave the stock a “sector outperform” rating in a research note on Thursday, November 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of American Healthcare REIT in a report on Wednesday, January 21st. Jefferies Financial Group reissued a “buy” rating on shares of American Healthcare REIT in a report on Monday, December 15th. Finally, BMO Capital Markets assumed coverage on American Healthcare REIT in a research report on Thursday, January 29th. They issued an “outperform” rating and a $55.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, American Healthcare REIT currently has an average rating of “Moderate Buy” and a consensus price target of $52.92.

View Our Latest Analysis on AHR

American Healthcare REIT Stock Performance

AHR traded up $0.91 during trading on Monday, hitting $53.15. The stock had a trading volume of 1,426,309 shares, compared to its average volume of 2,913,863. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.44 and a quick ratio of 0.44. The company has a 50 day moving average price of $48.83 and a 200-day moving average price of $46.19. American Healthcare REIT has a one year low of $26.48 and a one year high of $54.67. The firm has a market cap of $9.40 billion, a price-to-earnings ratio of 129.53, a P/E/G ratio of 1.97 and a beta of 1.03.

American Healthcare REIT (NYSE:AHRGet Free Report) last posted its earnings results on Thursday, February 26th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.40). American Healthcare REIT had a return on equity of 2.80% and a net margin of 3.09%.The firm had revenue of $604.08 million for the quarter, compared to analyst estimates of $617.49 million. During the same period in the prior year, the business posted $0.40 EPS. The firm’s quarterly revenue was up 11.3% compared to the same quarter last year. American Healthcare REIT has set its FY 2026 guidance at 1.990-2.050 EPS. As a group, research analysts predict that American Healthcare REIT will post 1.41 EPS for the current year.

Insider Buying and Selling at American Healthcare REIT

In other American Healthcare REIT news, Director Jeffrey T. Hanson sold 19,208 shares of the business’s stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average price of $48.40, for a total transaction of $929,667.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.92% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On American Healthcare REIT

Several hedge funds and other institutional investors have recently made changes to their positions in AHR. AQR Capital Management LLC lifted its stake in American Healthcare REIT by 170.1% in the 1st quarter. AQR Capital Management LLC now owns 25,275 shares of the company’s stock valued at $766,000 after purchasing an additional 15,918 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of American Healthcare REIT by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 90,521 shares of the company’s stock worth $2,743,000 after buying an additional 3,954 shares in the last quarter. NewEdge Advisors LLC lifted its stake in shares of American Healthcare REIT by 9.4% in the 1st quarter. NewEdge Advisors LLC now owns 23,509 shares of the company’s stock valued at $712,000 after acquiring an additional 2,011 shares during the last quarter. Focus Partners Wealth boosted its holdings in shares of American Healthcare REIT by 6.6% during the 1st quarter. Focus Partners Wealth now owns 25,809 shares of the company’s stock valued at $782,000 after acquiring an additional 1,591 shares in the last quarter. Finally, Acadian Asset Management LLC bought a new stake in American Healthcare REIT during the 1st quarter worth $185,000. 16.68% of the stock is owned by institutional investors.

American Healthcare REIT Company Profile

(Get Free Report)

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.

See Also

Analyst Recommendations for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.